Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 2,083 | 1,898 | 2,477 | 2,384 | 3,448 |
| Operating Income | -2,083 | -1,898 | -2,477 | -2,384 | -3,448 |
| Interest Expense | 0 | 0 | 0 | 0 | -2 |
| Other Income | -1 | 19 | 22 | -1,029 | 631 |
| Pre-tax Income | -2,084 | -1,879 | -2,455 | -3,414 | -2,816 |
| Income Tax | N/A | N/A | 2 | 36 | -7 |
| Net Income Continuous | -2,084 | -1,879 | -2,457 | -3,449 | -2,809 |
| Net Income | $-2,084 | $-1,879 | $-2,457 | $-3,436 | $-2,822 |
| EPS Basic Total Ops | -43.10 | -44.66 | -110.56 | -259.18 | -233.98 |
| EPS Basic Continuous Ops | -43.10 | -44.59 | -110.57 | -260.21 | -233.52 |
| EPS Diluted Total Ops | -43.10 | -44.66 | -110.56 | -259.18 | -233.98 |
| EPS Diluted Continuous Ops | -43.10 | -44.59 | -110.57 | -260.21 | -233.52 |
| EPS Diluted Before Non-Recurring Items | -43.20 | -45.00 | -109.79 | N/A | N/A |
| EBITDA(a) | $-1,998 | $-1,813 | $-2,392 | $-2,300 | $-3,353 |